Novel transurethral resection technologies and training modalities in the management of nonmuscle invasive bladder cancer: a comprehensive review

Standard

Novel transurethral resection technologies and training modalities in the management of nonmuscle invasive bladder cancer: a comprehensive review. / Schuettfort, Victor M; Pradere, Benjamin; Compérat, Eva; Abufaraj, Mohammad; Shariat, Shahrokh F.

In: CURR OPIN UROL, Vol. 31, No. 4, 01.07.2021, p. 324-331.

Research output: SCORING: Contribution to journalSCORING: Review articleResearch

Harvard

APA

Vancouver

Bibtex

@article{cf1867c4c6f6456e903c652febb47cc1,
title = "Novel transurethral resection technologies and training modalities in the management of nonmuscle invasive bladder cancer: a comprehensive review",
abstract = "PURPOSE OF REVIEW: Conventional transurethral resection (TURBT) with tumor fragmentation is the primary step in the surgical treatment of nonmuscle invasive bladder cancer. Recently, new surgical techniques and training modalities have emerged with the aim to overcome short-comings of TURBT and improve oncologic outcomes. In this review, we provide a comprehensive update of recent techniques/techniques that aim to improve upon conventional TURBT and beyond.RECENT FINDINGS: A systemic approach during conventional TURBT that features the use of a surgical checklist has been shown to improve recurrence-free survival. Several simulators have been developed and validated to provide additional training opportunities. However, transfer of improved simulator performance into real world surgery still requires validation. While there is no convincing data that demonstrate superior outcomes with bipolar TURBT, en-bloc resection already promises to offer lower rates of complications as well as potentially lower recurrence probabilities in select patients.SUMMARY: TURBT remains the quintessential procedure for the diagnosis and treatment of bladder cancer. Urologists need to be aware of the importance and challenges of this procedure. Aside of embracing new resection techniques and a conceptual-systematic approach, training opportunities should be expanded upon to improve patient outcomes.",
keywords = "Cystectomy/adverse effects, Humans, Neoplasm Recurrence, Local, Urinary Bladder Neoplasms/surgery, Urologic Surgical Procedures/adverse effects, Urologists",
author = "Schuettfort, {Victor M} and Benjamin Pradere and Eva Comp{\'e}rat and Mohammad Abufaraj and Shariat, {Shahrokh F}",
note = "Copyright {\textcopyright} 2021 Wolters Kluwer Health, Inc. All rights reserved.",
year = "2021",
month = jul,
day = "1",
doi = "10.1097/MOU.0000000000000892",
language = "English",
volume = "31",
pages = "324--331",
journal = "CURR OPIN UROL",
issn = "0963-0643",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

RIS

TY - JOUR

T1 - Novel transurethral resection technologies and training modalities in the management of nonmuscle invasive bladder cancer: a comprehensive review

AU - Schuettfort, Victor M

AU - Pradere, Benjamin

AU - Compérat, Eva

AU - Abufaraj, Mohammad

AU - Shariat, Shahrokh F

N1 - Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

PY - 2021/7/1

Y1 - 2021/7/1

N2 - PURPOSE OF REVIEW: Conventional transurethral resection (TURBT) with tumor fragmentation is the primary step in the surgical treatment of nonmuscle invasive bladder cancer. Recently, new surgical techniques and training modalities have emerged with the aim to overcome short-comings of TURBT and improve oncologic outcomes. In this review, we provide a comprehensive update of recent techniques/techniques that aim to improve upon conventional TURBT and beyond.RECENT FINDINGS: A systemic approach during conventional TURBT that features the use of a surgical checklist has been shown to improve recurrence-free survival. Several simulators have been developed and validated to provide additional training opportunities. However, transfer of improved simulator performance into real world surgery still requires validation. While there is no convincing data that demonstrate superior outcomes with bipolar TURBT, en-bloc resection already promises to offer lower rates of complications as well as potentially lower recurrence probabilities in select patients.SUMMARY: TURBT remains the quintessential procedure for the diagnosis and treatment of bladder cancer. Urologists need to be aware of the importance and challenges of this procedure. Aside of embracing new resection techniques and a conceptual-systematic approach, training opportunities should be expanded upon to improve patient outcomes.

AB - PURPOSE OF REVIEW: Conventional transurethral resection (TURBT) with tumor fragmentation is the primary step in the surgical treatment of nonmuscle invasive bladder cancer. Recently, new surgical techniques and training modalities have emerged with the aim to overcome short-comings of TURBT and improve oncologic outcomes. In this review, we provide a comprehensive update of recent techniques/techniques that aim to improve upon conventional TURBT and beyond.RECENT FINDINGS: A systemic approach during conventional TURBT that features the use of a surgical checklist has been shown to improve recurrence-free survival. Several simulators have been developed and validated to provide additional training opportunities. However, transfer of improved simulator performance into real world surgery still requires validation. While there is no convincing data that demonstrate superior outcomes with bipolar TURBT, en-bloc resection already promises to offer lower rates of complications as well as potentially lower recurrence probabilities in select patients.SUMMARY: TURBT remains the quintessential procedure for the diagnosis and treatment of bladder cancer. Urologists need to be aware of the importance and challenges of this procedure. Aside of embracing new resection techniques and a conceptual-systematic approach, training opportunities should be expanded upon to improve patient outcomes.

KW - Cystectomy/adverse effects

KW - Humans

KW - Neoplasm Recurrence, Local

KW - Urinary Bladder Neoplasms/surgery

KW - Urologic Surgical Procedures/adverse effects

KW - Urologists

U2 - 10.1097/MOU.0000000000000892

DO - 10.1097/MOU.0000000000000892

M3 - SCORING: Review article

C2 - 33973535

VL - 31

SP - 324

EP - 331

JO - CURR OPIN UROL

JF - CURR OPIN UROL

SN - 0963-0643

IS - 4

ER -